Immune response to Pneumocystis in simian model of AIDS
艾滋病猿模型对肺孢子菌的免疫反应
基本信息
- 批准号:7325716
- 负责人:
- 金额:$ 58.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAddressAlveolarAlveolitisAnimal TestingAnimalsAntibodiesAntibody FormationAntigensB-LymphocytesBiological Response ModifiersBlood specimenBronchoalveolar Lavage FluidCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsChronicClinicalCollaborationsDataDevelopmentDiseaseDisease ProgressionEventExhibitsExposure toHIVHIV InfectionsHumoral ImmunitiesIL8 geneImmuneImmune System DiseasesImmune responseImmunoglobulin Class SwitchingImmunologyImmunosuppressionImmunotherapyInfectionInfection ControlInfiltrationInflammatoryInflammatory ResponseInjuryInterferon Type IIInterleukin-10Liquid substanceLongitudinal StudiesLungLung InflammationLung diseasesLymphocyteMacacaMeasuresMediatingMediator of activation proteinMemoryModelingMonkeysMorbidity - disease rateNatureNumbersOutcomePathogenesisPathologyPatientsPhasePhysiologicalPhysiologyPlasmaPneumocystisPneumocystis carinii PneumoniaPreventionProductionRecombinantsReportingResearch PersonnelRespiratory physiologyRoleSIVSamplingSpecificityStructure of parenchyma of lungSymptomsT-LymphocyteTestingTherapeutic immunosuppressionTissuesVirusVirus ReplicationWeekWhole Body Plethysmographybasecytokineimmunosuppressedlung injurymacrophagemortalityneutrophilnonhuman primatenovelpathogenperipheral bloodprotective effectpulmonary functionrespiratoryresponse
项目摘要
DESCRIPTION (provided by applicant): Pneumocystis pneumonia (PCP) remains an important cause of morbidity and mortality in HIV-infected patients. CD4+ T cells are critical to clearance of Pneumocystis (Pc), however the role of other immune effectors in controlling this infection or in promoting lung tissue injury is less clear. The presence PC in the lung induces an intense inflammatory response, but the physiologic significance of this response is not well understood, and HIV infection itself can result in inflammatory responses that may cause acute or chronic lung injury. We have developed a novel, non-human primate model of SIV and PC co-infection that closely represents the immune dysfunctions of AIDS, and we propose to use this model to study the interaction of SIV and PC to identify immune mediators that may be exploited to better control PC infection and ameliorate lung injury. The specific aims of this proposal are: 1) To test the hypothesis that the CD8 T cell-predominant lymphocytic alveolitis associated with PC in SIV-infected monkeys and the resultant inflammatory response leads to worsening SIV infection and progression to AIDS. The specificity and function of the infiltrating cells will be determined, and we will determine whether this response has a protective or detrimental effect on disease progression; 2) To test the hypothesis that specific inflammatory responses associated with prolonged PC colonization and infection in SIV-infected monkeys leads to chronic lung injury and worsening pulmonary function. We will measure cellular composition and inflammatory mediators in bronchoalveolar lavage fluid and correlate changes in local immune responses with alterations in lung function. In addition, we will test the effect of local delivery of interleukin-10 in control of lung inflammation and injury; 3) To test the hypothesis that a local humoral response contributes to clearance of PC in SIV-infected monkeys. We will characterize the nature and function of anti-Pc antibodies in serial BAL and plasma samples from SIV/Pc inoculated animals and test the effect of previous exposure to PC antigens and Th2 skewing of the response on the capacity of SIV/Pc-inoculated animals to control the infection. These studies will begin to identify both protective and detrimental immune responses to PC in the context of AIDS immunosuppression and help to characterize novel avenues for immunotherapy and prevention of immune-mediated lung injury in AIDS-associated PC infection.
描述(由申请人提供):肺炎囊肿(PCP)仍然是HIV感染患者发病率和死亡率的重要原因。 CD4+ T细胞对于清除肺炎(PC)至关重要,但是其他免疫效应子在控制这种感染或促进肺组织损伤中的作用尚不清楚。肺中的PC存在引起强烈的炎症反应,但是该反应的生理意义尚不清楚,HIV感染本身可能导致炎症反应,可能导致急性或慢性肺损伤。我们已经开发了一种新型的,非人类的灵长类动物模型的SIV和PC共同感染,该模型密切代表了艾滋病的免疫功能障碍,我们建议使用该模型研究SIV和PC的相互作用,以鉴定可以利用的免疫介体,以更好地控制PC感染并延伸肺损伤。该提案的具体目的是:1)检验以下假设:与PC相关的CD8 T细胞促性淋巴细胞肺泡炎与SIV感染的猴子相关,并且由此产生的炎症反应会导致SIV感染恶化和对AIDS的进展。将确定浸润细胞的特异性和功能,我们将确定该反应对疾病进展是否具有保护性或有害作用。 2)检验以下假设:SIV感染猴子中与长时间PC定植和感染相关的特定炎症反应会导致慢性肺损伤和肺功能恶化。我们将测量支气管肺泡灌洗液中的细胞组成和炎症介质,并将局部免疫反应的变化与肺功能的改变相关。此外,我们将测试白介素10在控制肺部炎症和损伤方面的局部递送的影响; 3)测试局部体液反应有助于在SIV感染的猴子中清除PC的假设。我们将表征来自SIV/PC接种动物的连续BAL和血浆样品中抗PC抗体的性质和功能,并测试先前暴露于PC抗原的接触以及TH2反应对SIV/PC内部动物的能力控制感染的影响。这些研究将在AIDS免疫抑制的背景下开始鉴定对PC的保护性和有害免疫反应,并有助于表征与AIDS相关PC感染中免疫疗法和预防免疫介导的肺损伤的新型途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen A Norris其他文献
Karen A Norris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen A Norris', 18)}}的其他基金
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10269922 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10119736 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
- 批准号:
10605177 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
- 批准号:
10382422 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10685614 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10470252 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Immunopathogenesis of HIV-associated pulmonary hypertension
HIV相关肺动脉高压的免疫发病机制
- 批准号:
9370162 - 财政年份:2016
- 资助金额:
$ 58.03万 - 项目类别:
Immune dysfunction and pulmonary hypertension in primate model of HIV infection
HIV感染灵长类动物模型中的免疫功能障碍和肺动脉高压
- 批准号:
9404231 - 财政年份:2014
- 资助金额:
$ 58.03万 - 项目类别:
Serologic memory and prevention of Pneumocystis-related COPD in AIDS macaque mode
艾滋病猕猴模型肺孢子虫相关慢性阻塞性肺病的血清学记忆和预防
- 批准号:
8298380 - 财政年份:2011
- 资助金额:
$ 58.03万 - 项目类别:
相似国自然基金
JAK/STAT3调控星形胶质细胞表型在急性缺血性脑小血管病白质损伤中的作用和机制
- 批准号:82301661
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FBXO6在急性肺损伤巨噬细胞炎性活化中的作用及机制
- 批准号:82300101
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胰腺交感神经在急性胰腺炎后β细胞损伤和去分化中的作用及机制研究
- 批准号:82300736
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tlr4/Hif-1α/Nur77通路调控巨噬细胞代谢重编程介导急性肾移植排斥反应的机制研究
- 批准号:82300853
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Targeting the transcription factor c-Myb to address acute myeloid leukemia (AML)
靶向转录因子 c-Myb 来治疗急性髓系白血病 (AML)
- 批准号:
440373522 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
WBP Fellowship
Multi-organ human-on-a-chip system to address overdose and acute and chronic efficacy and off-target toxicity
多器官人体芯片系统解决用药过量、急慢性疗效和脱靶毒性问题
- 批准号:
10351973 - 财政年份:2019
- 资助金额:
$ 58.03万 - 项目类别:
Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure
转化新型药物和重新用途药物以解决芥末暴露的急性和迟发影响
- 批准号:
10007605 - 财政年份:2018
- 资助金额:
$ 58.03万 - 项目类别:
Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure
转化新型药物和重新用途药物以解决芥末暴露的急性和迟发影响
- 批准号:
10242669 - 财政年份:2018
- 资助金额:
$ 58.03万 - 项目类别:
Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure
转化新型药物和重新利用药物以解决芥末暴露的急性和迟发影响
- 批准号:
9145458 - 财政年份:2017
- 资助金额:
$ 58.03万 - 项目类别: